Company / EPS (Diluted)
INSMED Inc EPS (Diluted) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$5.34
FY2025
5-year range
-$5.34 / -$3.01
FY2021-FY2025
Trend
-36.6%
vs FY2024
Sector context
#179 of 204
Health Care
What the data says
INSMED Inc's eps (diluted) of $-5.34 is lower than 88% of companies in the Health Care sector (FY2025). EPS (Diluted) has declined for 3 consecutive years, from $-3.01 in FY2022 to $-5.34 in FY2025.
Based on SEC 10-K filings.
-5.34 in FY2025.
Declined from $-3.88 to $-5.34 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 204This company -$5.34 Sector average -$0.89
▼
-502.6% below sector average
Key checks
Key Insights
- INSMED Inc's eps (diluted) has declined for 3 consecutive years.
- In FY2025, eps (diluted) decreased 36.6% year-over-year.
- Ranks #179 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.34 | -36.6% |
| FY2024 | -$3.91 | -0.8% |
| FY2023 | -$3.88 | -28.9% |
| FY2022 | -$3.01 | +0.0% |
| FY2021 | -$3.01 | +28.7% |
| FY2020 | -$4.22 | -46.0% |
| FY2019 | -$2.89 | -1.4% |
| FY2018 | -$2.85 | -41.1% |
| FY2017 | -$2.02 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026